Connect your AI

HealthEquity HQY Share Repurchase Program, Authorized, Amount

Share Repurchase Program, Authorized, Amount at other companies

MetLifeMET

——

Other financials

Income statement

Revenue$354.6M+7.2%

Gross profit$256.3M+14.3%

Operating income$103.0M+23.9%

Net income$69.4M+28.8%

EPS (diluted)$0.82+34.4%

Balance sheet

Cash & equivalents$265.4M-7.8%

Total debt$984.7M-11.0%

Total equity$2.0B-3.6%

Total assets$3.3B-3.2%

Cash flow

Operating cash flow$97.5M+50.6%

CapEx$362.0K+321%

Free cash flow$97.2M+50.3%

Valuation

Market cap$7.12B-6.7%

Enterprise value$7.84B-7.2%

P/E30.9×-31.8×

P/S5.3×-0.8×

Profitability

Gross margin70.7%+5.2pp

Operating margin25.6%+9.2pp

Net margin17.3%+7.5pp

FCF margin36.5%+9.3pp

Returns & leverage

Return on equity11.1%+5.3pp

Debt / equity0.5×0.0×

Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept srt:StockRepurchaseProgramAuthorizedAmount1.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's share repurchase program, authorized, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is HealthEquity's share repurchase program, authorized, amount?: HealthEquity (HQY) reported share repurchase program, authorized, amount of $300M in Q3 2024.